Invex Therapeutics Ltd.ASX: IXC

Invex Therapeutics: Notice of Annual General Meeting/Proxy Form

· Issued by Invex Therapeutics Ltd. via ASX

Filed with ASX · · 12 pages · English

Summary by 6ix AI

The meeting will cover several resolutions, including the adoption of the remuneration report and the re-election of a director. Shareholders are encouraged to vote by proxy or in person, with specific instructions provided in the notice. The notice also includes an explanatory statement detailing the business to be discussed at the meeting.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/notice-of-annual-general-meetingproxy-form-535

Release

All Registry communications to: Automic Group GPO Box 5193 Sydney NSW 2001 Telephone (free call within Australia): 1300 288 664 ASX Code: IXC 21 October 2026 Upcoming Annual General Meeting of Shareholders Dear Shareholder, Invex Therapeutics Ltd ACN 632 145 334 (ASX: IXC or “the Company”),...

Invex Therapeutics Ltd. on 6ix

Earlier from Invex Therapeutics

Later from Invex Therapeutics

All Invex Therapeutics news releases